Gracell Biotechnologies Inc.
Related Filers (14)
- William Cao Wei (9)
- ORBIMED ADVISORS LLC (6)
- BANK OF NEW YORK / ADR DIVISION (2)
- LAV Biosciences Fund V, L.P. (2)
- Capital International Investors (2)
- BlackRock Inc. (2)
- WELLINGTON MANAGEMENT GROUP LLP (2)
- Frazier Life Sciences Public Fund, L.P. (2)
- ORBIMED CAPITAL LLC (2)
- Vivo Opportunity Fund Holdings, L.P. (2)
- RA CAPITAL MANAGEMENT, L.P. (2)
- Temasek Holdings (Private) Ltd (2)
- TLS Beta Pte. Ltd. (1)
- Sio Capital Management, LLC (1)
- Show More ...
Other (94)
6-K
Tuesday, 1/30/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/17/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/8/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/2/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 12/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 11/21/2023
Filing for proposed sale of securities under Rule 144
6-K
Tuesday, 11/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Thursday, 10/12/2023
Filing for proposed sale of securities under Rule 144
6-K
Friday, 9/29/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Monday, 9/25/2023
Notice of Effectiveness
CORRESP
Thursday, 9/21/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 9/12/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3/A
Tuesday, 9/12/2023
Registration statement for specified transactions by certain foreign private issuers
CORRESP
Wednesday, 9/6/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Thursday, 8/24/2023
Registration statement for specified transactions by certain foreign private issuers
144
Wednesday, 8/23/2023
Filing for proposed sale of securities under Rule 144
6-K
Monday, 8/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/7/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 6/20/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 6/16/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 6/15/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 6/15/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 6/15/2023
Filing for proposed sale of securities under Rule 144
6-K
Wednesday, 6/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 4/25/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
144
Thursday, 4/13/2023
Filing for proposed sale of securities under Rule 144
6-K
Thursday, 3/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/7/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Friday, 1/6/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Friday, 1/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/18/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Thursday, 6/30/2022
Notice of Effectiveness
CORRESP
Tuesday, 6/28/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 6/17/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3/A
Friday, 6/17/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Tuesday, 6/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Thursday, 5/19/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3/A
Thursday, 5/19/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Tuesday, 5/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Thursday, 4/28/2022
Registration statement for specified transactions by certain foreign private issuers
20-F
Friday, 4/22/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Monday, 4/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/24/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/22/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/16/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/18/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/12/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/4/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/21/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/20/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/11/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Friday, 4/23/2021
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Monday, 4/12/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/6/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/15/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
SEC STAFF LETTER
Monday, 1/25/2021
None
CERT
Thursday, 1/7/2021
Certification by an exchange approving securities for listing
F-1/A
Thursday, 1/7/2021
Registration statement for securities of certain foreign private issuers
EFFECT
Thursday, 1/7/2021
Notice of Effectiveness
EFFECT
Thursday, 1/7/2021
Notice of Effectiveness
CORRESP
Wednesday, 1/6/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 1/6/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 1/6/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Wednesday, 1/6/2021
Registration statement for securities of certain foreign private issuers
F-6/A
Tuesday, 1/5/2021
Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
CORRESP
Monday, 1/4/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Monday, 1/4/2021
Registration statement for securities of certain foreign private issuers
8-A12B
Monday, 1/4/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
F-6
Monday, 1/4/2021
Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
SEC STAFF LETTER
Tuesday, 12/29/2020
None
CORRESP
Monday, 12/21/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 12/18/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1
Friday, 12/18/2020
Registration statement for securities of certain foreign private issuers
Ownership (25)
SC 13G/A
Wednesday, 2/14/2024
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
William Cao Wei: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Sio Capital Management, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Vivo Opportunity Fund Holdings, L.P.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
LAV Biosciences Fund V, L.P.: Major Shareholders
SC 13G/A
Thursday, 10/19/2023
Temasek Holdings (Private) Ltd: Major Shareholders
SC 13G
Monday, 8/21/2023
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G
Friday, 8/18/2023
Vivo Opportunity Fund Holdings, L.P.: Major Shareholders
SC 13D/A
Friday, 8/11/2023
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D
Friday, 3/31/2023
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G/A
Wednesday, 3/8/2023
BlackRock Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Frazier Life Sciences Public Fund, L.P.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Capital International Investors: Major Shareholders
SC 13G/A
Tuesday, 2/7/2023
William Cao Wei: Major Shareholders
SC 13G/A
Monday, 2/6/2023
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G
Friday, 2/3/2023
BlackRock Inc.: Major Shareholders
SC 13G
Thursday, 3/17/2022
Frazier Life Sciences Public Fund, L.P.: Major Shareholders
SC 13G
Monday, 2/14/2022
William Cao Wei: Major Shareholders
SC 13G
Friday, 2/11/2022
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G
Friday, 2/11/2022
Capital International Investors: Major Shareholders
SC 13G
Wednesday, 2/9/2022
LAV Biosciences Fund V, L.P.: Major Shareholders
SC 13G
Friday, 2/4/2022
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13D
Thursday, 1/21/2021
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G
Friday, 1/15/2021
Temasek Holdings (Private) Ltd: Major Shareholders
Prospectus (8)
S-8
Wednesday, 2/1/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Thursday, 2/25/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Friday, 1/8/2021
Prospectus filed pursuant to Rule 424(b)(4)
FWP
Thursday, 1/7/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
DRSLTR
Tuesday, 11/24/2020
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 11/24/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Monday, 10/19/2020
Correspondence Related to Draft Registration Statement
DRS
Monday, 10/19/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy